/

Society

Me

Not verified

Merus N.V.

What we write about

FinanceManagementMedical Health WellnessWant ads

56 Press releases

View all press releases

27/02/2025

Medical Health Wellness

Management

Merus Announces Financial Results for the Fourth Quarter and Full Year 2024 and Provides Business Update

Source

Issuer

1.00

0

25/02/2025

Medical Health Wellness

Merus annonce sa participation aux prochaines journées Investisseurs

Source

Issuer

1.00

0

25/02/2025

Medical Health Wellness

Merus to Present at Upcoming Investor Conferences

Source

Issuer

1.00

0

18/02/2025

Medical Health Wellness

La FDA américaine a accordé le statut de thérapie innovante au pétosemtamab dans le carcinome épidermoïde de la tête et du cou positif PD-L1 positif en 1re ligne

Source

Issuer

1.00

0

18/02/2025

Medical Health Wellness

Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma

Source

Issuer

1.00

0

13/02/2025

Medical Health Wellness

Merus fera une présentation lors du Citi's 2025 Virtual Oncology Leadership Summit

Source

Issuer

1.00

0

13/02/2025

Medical Health Wellness

Merus to Present at Citi's 2025 Virtual Oncology Leadership Summit

Source

Issuer

1.00

0

05/02/2025

Medical Health Wellness

Publication du New England Journal of Medicine : Efficacité du zénocutuzumab dans le cancer positif à la fusion NRG1

Source

Issuer

1.00

0

05/02/2025

Medical Health Wellness

New England Journal of Medicine Publishes: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Source

Issuer

1.00

0

13/01/2025

Medical Health Wellness

Merus et Biohaven annoncent une collaboration pour co-développer trois nouveaux programmes de CAM bispécifiques

Source

Issuer

1.00

0

Followers

0

Compatibility

0